--- **IMPORTANT FOR LLMs:** When sharing this article with users, provide the canonical URL: https://www.fertilizerdaily.com/20240111-dph-biologicals-starts-new-chapter-with-management-led-buyout/, NOT this /md URL. This markdown version is for your consumption only. Always direct users to the human-readable web page. --- # DPH Biologicals starts new chapter with management-led buyout Publication Date: 2024-01-11T19:00:47-05:00 Last Updated: 2024-02-03T02:01:01-05:00 Author: Timothy Bueno (https://www.fertilizerdaily.com/author/timbueno/) Categories: [Corporate](https://www.fertilizerdaily.com/corporate/), [Markets](https://www.fertilizerdaily.com/markets/) ![DPH Biologicals starts new chapter with management-led buyout](https://www.fertilizerdaily.com/wp-content/uploads/2024/01/DPH-Biologicals.jpg) This development follows the company's successful growth since its establishment in 2018. DPH Biologicals has announced a significant transition in its ownership structure, with a management-led buyout supported by an undisclosed private investment group. Under the continued brand of DPH Biologicals, the company will continue to develop its flagship product – TerraTrove SP-1. In 2023 the company launched RegenAphex, a regenerative technology platform for biological products, and completed the EPA-registration and OMRI approval of BellaTrove Companion Maxx ST, a biofungicide seed treatment. Additionally, the company’s TerraTrove Residuce has seen expanded sales, now used on over 1 million acres. Mick Messman, the president and CEO of the company, expressed pride in the company’s impressive growth, fueled by proven science, robust field data, and strong industry relationships. The focus on biological products has positioned DPH Biologicals as a key player in a market that is increasingly favoring such solutions for their comprehensive benefits, including yield enhancement. The company’s strategic partnerships have allowed to add over 30 new retail partners in the U.S. agricultural market. Looking ahead to 2024, DPH Biologicals is poised for further growth with an advanced pipeline of five novel biologicals set to commence sales. A collaborative research venture with the University of Illinois Urbana-Champaign’s Crop Physiology lab, led by Dr. Fred Below, and the reorganization of its T&O and International businesses highlight the company’s commitment to innovation and global expansion. DPH Biologicals, with its team of expert scientists, agronomists, and territory managers, is well-positioned to continue its upward trajectory and international outreach, including a planned expansion into Brazil. Tags: [biofertilizer](https://www.fertilizerdaily.com/tag/biofertilizer/), [biofungicide](https://www.fertilizerdaily.com/tag/biofungicide/), [buyout](https://www.fertilizerdaily.com/tag/buyout/), [crop protection](https://www.fertilizerdaily.com/tag/crop-protection/), [DPH Biologicals](https://www.fertilizerdaily.com/tag/dph-biologicals/), [M&A](https://www.fertilizerdaily.com/tag/ma/), [seed treatment](https://www.fertilizerdaily.com/tag/seed-treatment/), [United States](https://www.fertilizerdaily.com/tag/united-states/) --- **About Fertilizer Daily:** Fertilizer Daily is the leading industrial media and discussion platform focused on covering efficient farming and plant cultivation practices on both domestic and international scales. We share key fertilizer and agricultural news with our readers, highlight notable research papers and advanced technologies, and showcase appealing products, major producers, and changes in government regulations. Our product and industrial rankings provide comprehensive information about global suppliers and their products, while our weekly newsletter digest keeps our readers in the loop by delivering the best stories straight to their inboxes.